This report aims to provide a comprehensive presentation of the global market for Vulvar and Vaginal Atrophy Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vulvar and Vaginal Atrophy Therapy. This report contains market size and forecasts of Vulvar and Vaginal Atrophy Therapy in global, including the following market information:
Global Vulvar and Vaginal Atrophy Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Vulvar and Vaginal Atrophy Therapy Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Vulvar and Vaginal Atrophy Therapy companies in 2022 (%)
The global Vulvar and Vaginal Atrophy Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Vulvar Atrophy Therapy Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Vulvar and Vaginal Atrophy Therapy include Almirall, VenusConcept, Alma Lasers, ThermiGen LLC, Lutronic, BTL Group of Companies, Viveve, Fotona and Hologic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Vulvar and Vaginal Atrophy Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vulvar and Vaginal Atrophy Therapy Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Vulvar and Vaginal Atrophy Therapy Market Segment Percentages, by Type, 2022 (%)
Vulvar Atrophy Therapy
Vaginal Atrophy Therapy
Global Vulvar and Vaginal Atrophy Therapy Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Vulvar and Vaginal Atrophy Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Global Vulvar and Vaginal Atrophy Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Vulvar and Vaginal Atrophy Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vulvar and Vaginal Atrophy Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Vulvar and Vaginal Atrophy Therapy revenues share in global market, 2022 (%)
Key companies Vulvar and Vaginal Atrophy Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Vulvar and Vaginal Atrophy Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Almirall
VenusConcept
Alma Lasers
ThermiGen LLC
Lutronic
BTL Group of Companies
Viveve
Fotona
Hologic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vulvar and Vaginal Atrophy Therapy, market overview.
Chapter 2: Global Vulvar and Vaginal Atrophy Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Vulvar and Vaginal Atrophy Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vulvar and Vaginal Atrophy Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vulvar and Vaginal Atrophy Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Vulvar and Vaginal Atrophy Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vulvar and Vaginal Atrophy Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vulvar and Vaginal Atrophy Therapy Overall Market Size
2.1 Global Vulvar and Vaginal Atrophy Therapy Market Size: 2022 VS 2032
2.2 Global Vulvar and Vaginal Atrophy Therapy Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Vulvar and Vaginal Atrophy Therapy Sales: 2018-2032
3 Company Landscape
3.1 Top Vulvar and Vaginal Atrophy Therapy Players in Global Market
3.2 Top Global Vulvar and Vaginal Atrophy Therapy Companies Ranked by Revenue
3.3 Global Vulvar and Vaginal Atrophy Therapy Revenue by Companies
3.4 Global Vulvar and Vaginal Atrophy Therapy Sales by Companies
3.5 Global Vulvar and Vaginal Atrophy Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Vulvar and Vaginal Atrophy Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vulvar and Vaginal Atrophy Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vulvar and Vaginal Atrophy Therapy Players in Global Market
3.8.1 List of Global Tier 1 Vulvar and Vaginal Atrophy Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Vulvar and Vaginal Atrophy Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Vulvar and Vaginal Atrophy Therapy Market Size Markets, 2022 & 2032
4.1.2 Vulvar Atrophy Therapy
4.1.3 Vaginal Atrophy Therapy
4.2 By Type - Global Vulvar and Vaginal Atrophy Therapy Revenue & Forecasts
4.2.1 By Type - Global Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2023
4.2.2 By Type - Global Vulvar and Vaginal Atrophy Therapy Revenue, 2024-2032
4.2.3 By Type - Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
4.3 By Type - Global Vulvar and Vaginal Atrophy Therapy Sales & Forecasts
4.3.1 By Type - Global Vulvar and Vaginal Atrophy Therapy Sales, 2018-2023
4.3.2 By Type - Global Vulvar and Vaginal Atrophy Therapy Sales, 2024-2032
4.3.3 By Type - Global Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
4.4 By Type - Global Vulvar and Vaginal Atrophy Therapy Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vulvar and Vaginal Atrophy Therapy Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Specialty Clinics
5.1.5 Others
5.2 By Application - Global Vulvar and Vaginal Atrophy Therapy Revenue & Forecasts
5.2.1 By Application - Global Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2023
5.2.2 By Application - Global Vulvar and Vaginal Atrophy Therapy Revenue, 2024-2032
5.2.3 By Application - Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
5.3 By Application - Global Vulvar and Vaginal Atrophy Therapy Sales & Forecasts
5.3.1 By Application - Global Vulvar and Vaginal Atrophy Therapy Sales, 2018-2023
5.3.2 By Application - Global Vulvar and Vaginal Atrophy Therapy Sales, 2024-2032
5.3.3 By Application - Global Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
5.4 By Application - Global Vulvar and Vaginal Atrophy Therapy Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Vulvar and Vaginal Atrophy Therapy Market Size, 2022 & 2032
6.2 By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue & Forecasts
6.2.1 By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2023
6.2.2 By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue, 2024-2032
6.2.3 By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
6.3 By Region - Global Vulvar and Vaginal Atrophy Therapy Sales & Forecasts
6.3.1 By Region - Global Vulvar and Vaginal Atrophy Therapy Sales, 2018-2023
6.3.2 By Region - Global Vulvar and Vaginal Atrophy Therapy Sales, 2024-2032
6.3.3 By Region - Global Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2032
6.4.2 By Country - North America Vulvar and Vaginal Atrophy Therapy Sales, 2018-2032
6.4.3 US Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.4.4 Canada Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.4.5 Mexico Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2032
6.5.2 By Country - Europe Vulvar and Vaginal Atrophy Therapy Sales, 2018-2032
6.5.3 Germany Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.5.4 France Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.5.5 U.K. Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.5.6 Italy Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.5.7 Russia Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.5.8 Nordic Countries Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.5.9 Benelux Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2032
6.6.2 By Region - Asia Vulvar and Vaginal Atrophy Therapy Sales, 2018-2032
6.6.3 China Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.6.4 Japan Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.6.5 South Korea Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.6.6 Southeast Asia Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.6.7 India Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2032
6.7.2 By Country - South America Vulvar and Vaginal Atrophy Therapy Sales, 2018-2032
6.7.3 Brazil Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.7.4 Argentina Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales, 2018-2032
6.8.3 Turkey Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.8.4 Israel Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.8.5 Saudi Arabia Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
6.8.6 UAE Vulvar and Vaginal Atrophy Therapy Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Almirall
7.1.1 Almirall Company Summary
7.1.2 Almirall Business Overview
7.1.3 Almirall Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.1.4 Almirall Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Almirall Key News & Latest Developments
7.2 VenusConcept
7.2.1 VenusConcept Company Summary
7.2.2 VenusConcept Business Overview
7.2.3 VenusConcept Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.2.4 VenusConcept Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.2.5 VenusConcept Key News & Latest Developments
7.3 Alma Lasers
7.3.1 Alma Lasers Company Summary
7.3.2 Alma Lasers Business Overview
7.3.3 Alma Lasers Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.3.4 Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.3.5 Alma Lasers Key News & Latest Developments
7.4 ThermiGen LLC
7.4.1 ThermiGen LLC Company Summary
7.4.2 ThermiGen LLC Business Overview
7.4.3 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.4.4 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.4.5 ThermiGen LLC Key News & Latest Developments
7.5 Lutronic
7.5.1 Lutronic Company Summary
7.5.2 Lutronic Business Overview
7.5.3 Lutronic Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.5.4 Lutronic Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.5.5 Lutronic Key News & Latest Developments
7.6 BTL Group of Companies
7.6.1 BTL Group of Companies Company Summary
7.6.2 BTL Group of Companies Business Overview
7.6.3 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.6.4 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.6.5 BTL Group of Companies Key News & Latest Developments
7.7 Viveve
7.7.1 Viveve Company Summary
7.7.2 Viveve Business Overview
7.7.3 Viveve Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.7.4 Viveve Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Viveve Key News & Latest Developments
7.8 Fotona
7.8.1 Fotona Company Summary
7.8.2 Fotona Business Overview
7.8.3 Fotona Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.8.4 Fotona Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Fotona Key News & Latest Developments
7.9 Hologic
7.9.1 Hologic Company Summary
7.9.2 Hologic Business Overview
7.9.3 Hologic Vulvar and Vaginal Atrophy Therapy Major Product Offerings
7.9.4 Hologic Vulvar and Vaginal Atrophy Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Hologic Key News & Latest Developments
8 Global Vulvar and Vaginal Atrophy Therapy Production Capacity, Analysis
8.1 Global Vulvar and Vaginal Atrophy Therapy Production Capacity, 2018-2032
8.2 Vulvar and Vaginal Atrophy Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Vulvar and Vaginal Atrophy Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vulvar and Vaginal Atrophy Therapy Supply Chain Analysis
10.1 Vulvar and Vaginal Atrophy Therapy Industry Value Chain
10.2 Vulvar and Vaginal Atrophy Therapy Upstream Market
10.3 Vulvar and Vaginal Atrophy Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vulvar and Vaginal Atrophy Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Vulvar and Vaginal Atrophy Therapy in Global Market
Table 2. Top Vulvar and Vaginal Atrophy Therapy Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Vulvar and Vaginal Atrophy Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Vulvar and Vaginal Atrophy Therapy Revenue Share by Companies, 2018-2023
Table 5. Global Vulvar and Vaginal Atrophy Therapy Sales by Companies, (K Units), 2018-2023
Table 6. Global Vulvar and Vaginal Atrophy Therapy Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Vulvar and Vaginal Atrophy Therapy Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Vulvar and Vaginal Atrophy Therapy Product Type
Table 9. List of Global Tier 1 Vulvar and Vaginal Atrophy Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vulvar and Vaginal Atrophy Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Vulvar and Vaginal Atrophy Therapy Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Vulvar and Vaginal Atrophy Therapy Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Vulvar and Vaginal Atrophy Therapy Sales (K Units), 2018-2023
Table 15. By Type - Global Vulvar and Vaginal Atrophy Therapy Sales (K Units), 2024-2032
Table 16. By Application ? Global Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Vulvar and Vaginal Atrophy Therapy Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Vulvar and Vaginal Atrophy Therapy Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Vulvar and Vaginal Atrophy Therapy Sales (K Units), 2018-2023
Table 20. By Application - Global Vulvar and Vaginal Atrophy Therapy Sales (K Units), 2024-2032
Table 21. By Region ? Global Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Vulvar and Vaginal Atrophy Therapy Sales (K Units), 2018-2023
Table 25. By Region - Global Vulvar and Vaginal Atrophy Therapy Sales (K Units), 2024-2032
Table 26. By Country - North America Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2018-2023
Table 29. By Country - North America Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2024-2032
Table 30. By Country - Europe Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2018-2023
Table 33. By Country - Europe Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2024-2032
Table 34. By Region - Asia Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2018-2023
Table 37. By Region - Asia Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2024-2032
Table 38. By Country - South America Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2018-2023
Table 41. By Country - South America Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales, (K Units), 2024-2032
Table 46. Almirall Company Summary
Table 47. Almirall Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 48. Almirall Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Almirall Key News & Latest Developments
Table 50. VenusConcept Company Summary
Table 51. VenusConcept Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 52. VenusConcept Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. VenusConcept Key News & Latest Developments
Table 54. Alma Lasers Company Summary
Table 55. Alma Lasers Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 56. Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Alma Lasers Key News & Latest Developments
Table 58. ThermiGen LLC Company Summary
Table 59. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 60. ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. ThermiGen LLC Key News & Latest Developments
Table 62. Lutronic Company Summary
Table 63. Lutronic Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 64. Lutronic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Lutronic Key News & Latest Developments
Table 66. BTL Group of Companies Company Summary
Table 67. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 68. BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. BTL Group of Companies Key News & Latest Developments
Table 70. Viveve Company Summary
Table 71. Viveve Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 72. Viveve Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Viveve Key News & Latest Developments
Table 74. Fotona Company Summary
Table 75. Fotona Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 76. Fotona Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Fotona Key News & Latest Developments
Table 78. Hologic Company Summary
Table 79. Hologic Vulvar and Vaginal Atrophy Therapy Product Offerings
Table 80. Hologic Vulvar and Vaginal Atrophy Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Hologic Key News & Latest Developments
Table 82. Vulvar and Vaginal Atrophy Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Vulvar and Vaginal Atrophy Therapy Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Vulvar and Vaginal Atrophy Therapy Production by Region, 2018-2023 (K Units)
Table 85. Global Vulvar and Vaginal Atrophy Therapy Production by Region, 2024-2032 (K Units)
Table 86. Vulvar and Vaginal Atrophy Therapy Market Opportunities & Trends in Global Market
Table 87. Vulvar and Vaginal Atrophy Therapy Market Drivers in Global Market
Table 88. Vulvar and Vaginal Atrophy Therapy Market Restraints in Global Market
Table 89. Vulvar and Vaginal Atrophy Therapy Raw Materials
Table 90. Vulvar and Vaginal Atrophy Therapy Raw Materials Suppliers in Global Market
Table 91. Typical Vulvar and Vaginal Atrophy Therapy Downstream
Table 92. Vulvar and Vaginal Atrophy Therapy Downstream Clients in Global Market
Table 93. Vulvar and Vaginal Atrophy Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Vulvar and Vaginal Atrophy Therapy Segment by Type in 2022
Figure 2. Vulvar and Vaginal Atrophy Therapy Segment by Application in 2022
Figure 3. Global Vulvar and Vaginal Atrophy Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Vulvar and Vaginal Atrophy Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Vulvar and Vaginal Atrophy Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. Vulvar and Vaginal Atrophy Therapy Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Vulvar and Vaginal Atrophy Therapy Revenue in 2022
Figure 9. By Type - Global Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
Figure 11. By Type - Global Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
Figure 12. By Type - Global Vulvar and Vaginal Atrophy Therapy Price (USD/Unit), 2018-2032
Figure 13. By Application - Global Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
Figure 15. By Application - Global Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
Figure 16. By Application - Global Vulvar and Vaginal Atrophy Therapy Price (USD/Unit), 2018-2032
Figure 17. By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
Figure 20. By Region - Global Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
Figure 21. By Country - North America Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
Figure 22. By Country - North America Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
Figure 23. US Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
Figure 28. Germany Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. France Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
Figure 37. China Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. India Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
Figure 43. By Country - South America Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
Figure 44. Brazil Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Vulvar and Vaginal Atrophy Therapy Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales Market Share, 2018-2032
Figure 48. Turkey Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Vulvar and Vaginal Atrophy Therapy Revenue, (US$, Mn), 2018-2032
Figure 52. Global Vulvar and Vaginal Atrophy Therapy Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Vulvar and Vaginal Atrophy Therapy by Region, 2022 VS 2032
Figure 54. Vulvar and Vaginal Atrophy Therapy Industry Value Chain
Figure 55. Marketing Channels
